A Pill That Kills Ticks Is a Promising New Weapon Against Lyme Disease
If you have a dog or cat, chances are you’ve given your pet a flavored chewable tablet for tick prevention at some point. What if you could take a similar …
biotech
Scientists Are Inching Closer to Bringing Back the Woolly Mammoth
De-extinction startup Colossal Biosciences wants to bring back the woolly mammoth. Well, not the woolly mammoth exactly, but an Asian elephant gene-edited to give it the fuzzy hair and layer …
2054, Part VI: Standoff at Arlington
18:46 April 15, 2054 (GMT‑5) Arlington National Cemetery That night in her apartment Julia Hunt ordered in sushi and watched the coverage of Slake’s botched press conference on her living …
Chinese biotech firm Wuxi AppTec should be sanctioned as a security threat, US lawmakers tell White House officials
The US should review Chinese biotech firm Wuxi AppTec and its affiliate Wuxi Biologics for sanctions, a bipartisan group of lawmakers told top Biden administration officials on Monday. In a …
2054, Part V: From Tokyo With Love
Zhao Jin cast an appraising glance at Mohammad, who moved his food around on his plate and said, “He won’t be a senator for much longer.” “No,” Zhao Jin answered. …
2054, Part IV: A Nation Divided
Wisecarver stepped across the threshold. “Good morning, Mr. President.” He gave a little nod. Beneath his arm he carried a single binder. “Good morning, Trent.” Smith gestured for Wisecarver to …
2054, Part III: The Singularity
Lily didn’t want to approach B.T. She thought that might seem too aggressive; instead, she wanted him to notice her. At the roulette table, he had placed his chips on …
2054, Part II: Next Big Thing
A bloody Sunday followed. In Tucson, a Border Patrol officer fired a rubber bullet that struck a Truther protester in the eye, killing her. When the news broke, the Homeland …
2054, Part I: Death of a President
“But do you understand what you did wrong?” She struggled to look him directly in the eye. Her gaze instead fell over his shoulder, where the news was streaming live …
A Startup Has Unlocked a Way to Make Cheap Insulin
Now some key patents have expired, and the US Food and Drug Administration has paved the way for biosimilar versions of insulin—so-called because they’re almost identical to another product already …